B
BAFNAPH
₹88.87
-0.85 (0.95%)

Bafna Pharmaceuticals Ltd. (BAFNAPH) live share price today at NSE / BSE

Overview
Charts
Results
News & Events

Expert Verdict for Bafna Pharmaceuticals Ltd. (BAFNAPH) Share

View details
Today`s low
0.00
Today`s high
0.00
Today`s return
Bafna Pharmaceuticals Ltd. (BAFNAPH) Share Price Today
Performance Of Bafna Pharmaceuticals Ltd. (BAFNAPH) Share Today
Opening Price:91.53
Previous closing Price:89.72
Volume of Bafna Pharmaceuticals Ltd. (BAFNAPH) share:4,566
Value of Share:88.87
Fundamental of Bafna Pharmaceuticals Ltd. (BAFNAPH) Share Price
Market Capitalisation:211 Cr.
P/E Ratio:50.71
P/B Ratio:2.48
Sector P/E:45.61
EPS (TTM):1.76
Dividend Yield:0.00
14D - RSI:64.07
50 DMA:78.90
200 DMA:79.04

Note: The above data is mentioned as per the Bafna Pharmaceuticals Ltd. (BAFNAPH) share price today.

Bafna Pharmaceuticals Ltd. (BAFNAPH) Share Price Today At NSE

    • Live Bafna Pharmaceuticals Ltd. (BAFNAPH) Share Price NSE India: ₹88.87
    • Previous Closing Price: ₹89.72
    • Open Price: ₹91.53
    • High: ₹91.89
    • Low: ₹88.71

Bafna Pharmaceuticals Ltd. (BAFNAPH) Share Price Today At BSE

  • Live Bafna Pharmaceuticals Ltd. (BAFNAPH) Share Price BSE India: ₹89.00
  • Previous Closing Price: ₹90.06
  • Open Price: ₹89.94
  • High: ₹90.04
  • Low: ₹89.00

Historical Price Of Bafna Pharmaceuticals Ltd. (BAFNAPH) Share

The table below shows the variations in Bafna Pharmaceuticals Ltd. (BAFNAPH) share price from January 2018 to July 2025.

Month & YearPrice (INR)Open Price (INR)High Price (INR)Low Price (INR)Volume (Cr.)Change %
January 201824.7028.3529.8524.005,16,600-12.87
February 201826.9524.3530.0022.009,11,57310.68
March 201828.0027.0028.5023.803,32,3523.7
April 201827.7529.0030.7527.103,46,990-4.31
May 201824.8527.7530.4023.154,99,055-10.45
June 201823.0525.3526.4521.952,34,221-9.07
July 201822.2023.0024.7020.053,18,470-3.48
August 201819.5022.0023.0018.653,61,797-11.36
September 201812.3020.0021.8511.453,16,760-38.5
October 201814.2012.2015.5510.302,39,86016.39
November 201812.7514.4015.0012.501,58,434-11.46
December 201811.5512.5514.7011.002,05,570-7.97
January 201910.5011.4012.009.651,97,901-7.89
February 201910.0010.4011.007.903,21,393-3.85
March 20199.6510.2012.209.303,49,320-5.39
April 20198.809.6510.108.502,05,179-8.81
May 201911.108.5013.207.507,83,86730.59
June 20195.4511.1011.405.351,32,361-50.9
July 20195.705.457.004.751,02,5214.59
August 20193.555.705.703.5573,750-37.72
March 202013.304.4013.304.4011,515202.27
April 202020.3513.9520.3513.9514,91945.88
May 202020.3520.3520.3520.354,0720
June 202022.4020.3522.4020.353,60110.07
July 202022.4022.4022.4022.401,2230
August 202023.5022.4023.5021.301,9774.91
September 202041.7523.5041.7523.5010,15277.66
October 2020115.4043.80115.4043.8059,477163.47
November 2020133.90121.15211.65121.1595,28410.52
December 2020170.85127.25233.55120.902,05,25934.26
January 2021124.25162.35179.30122.0092,021-23.47
February 2021124.00124.25146.95110.0089,790-0.2
March 2021137.45121.55196.10117.052,79,49013.08
April 2021130.80130.60150.75117.901,97,3970.15
May 2021134.50125.50154.40124.302,94,1887.17
June 2021140.85137.20153.90130.002,15,4392.66
July 2021154.00139.00182.70133.003,38,03810.79
August 2021133.15161.70165.00128.151,01,759-17.66
September 2021128.45135.90137.40126.0093,980-5.48
October 2021121.80131.05144.60119.9091,053-7.06
November 2021117.15125.70149.15116.201,21,160-6.8
December 2021152.55117.00152.55113.301,85,89530.38
January 2022140.10155.60160.15130.401,23,365-9.96
February 2022121.00147.00185.50119.1010,43,013-17.69
March 2022126.65119.50145.00114.503,46,4245.98
April 2022135.55124.65140.00124.6573,8698.74
May 2022111.70139.70139.70111.7044,357-20.04
June 2022115.00116.95128.15108.001,24,396-1.67
July 2022108.90115.00115.85107.0017,978-5.3
August 2022114.75109.00123.50103.1526,2305.28
November 202387.7085.0091.4079.602,98,8193.18
December 202392.0088.80104.2587.802,47,5893.6
January 202498.0092.00107.8092.002,31,6866.52
February 202487.5098.00101.8086.001,50,916-10.71
March 202478.3590.9091.1075.901,49,646-13.81
April 202494.8079.0094.8078.2596,82320
May 202489.9599.50113.0089.9591,684-9.6
June 202475.4785.4585.4573.2538,534-11.68
July 202486.0079.2496.0079.2486,7438.53
August 202480.6886.0089.4080.0064,021-6.19
September 202484.9980.6888.0975.011,38,0945.34
October 202478.5687.7087.7077.2658,996-10.42
November 202479.9982.4683.4077.4720,432-3
December 202478.9079.9585.4077.5533,527-1.31
January 202580.0082.8487.490.0058,002-3.43
February 202573.5980.1083.0069.0038,369-8.13
March 202574.8073.5983.6669.9161,8981.64
April 202579.8875.0081.0070.6153,8236.51
May 202574.9881.0081.0071.5773,587-7.43
June 202584.0375.2584.0372.0174,27511.67
July 202588.8787.9094.9981.231,63,8821.1

Shareholding Pattern of Bafna Pharmaceuticals Ltd. (BAFNAPH) Shares In Stock Market

The below depicted shareholding pattern is as per the Bafna Pharmaceuticals Ltd. (BAFNAPH) Industries Ltd. Share Price Market of June 2025.

Promoters75.00%
Foreign Institutions9.34%
Retail and Others15.66%
Other Domestic Institutions0.00%
Mutual Funds0.00%
Bafna Pharmaceuticals Ltd. (BAFNAPH) Share Background
Face Value10.00
ISININE878I01022
Market Lot1.00
InstrumentEQUITY
Should you invest in Bafna Pharmaceuticals Ltd. (BAFNAPH) Industries Limited?
  • Every milestone results from a lot of hard work, effort, and making the correct decisions, but patience is essential.
  • Patience is the key to success in the share market, which is also important in attaining benefits on Bafna Pharmaceuticals Ltd. (BAFNAPH) share price.
  • In terms of investment, the investor’s patience pays off with a high return, which is why long-term investors are the most successful.
  • Bafna Pharmaceuticals Ltd. (BAFNAPH) Industries has produced a great return to the last year and is reaching new milestones daily; it has become the first Indian firm to attain a market capitalisation of 211 Cr.
  • Bafnaph FAQs

    Is Bafna Pharmaceuticals Ltd. a good stock to invest in?

    arrow

    Our expert verdict states that Bafna Pharmaceuticals Ltd. is in Buy zone for Short term and is in Sell zone for Long term.

    Should I buy Bafna Pharmaceuticals Ltd. share now?

    arrow

    As per our verdict, Bafna Pharmaceuticals Ltd. is in the Buy zone for Short term.

    Should I buy Bafna Pharmaceuticals Ltd. shares for the long term?

    arrow

    As per our verdict, Bafna Pharmaceuticals Ltd. is in Sell zone for Long term.

    What is Bafna Pharmaceuticals Ltd. share price today?

    arrow

    The Bafna Pharmaceuticals Ltd. share price today is 88.87.

    How to buy Bafna Pharmaceuticals Ltd. share?

    arrow

    You can buy Bafna Pharmaceuticals Ltd. shares on any demat broker by completing your KYC. Before buying any stock, check BUY/SELL/HOLD insights on the Univest App.

    What is the share price of Bafna Pharmaceuticals Ltd.?

    arrow

    The share price of Bafna Pharmaceuticals Ltd. is 88.87, please note that the price may vary on a real-time basis.

    What is the PE and PB ratio of Bafna Pharmaceuticals Ltd.?

    arrow

    PE ratio of Bafna Pharmaceuticals Ltd. is 50.71 and PB ratio of Bafna Pharmaceuticals Ltd. is 2.48.

    How’s PE of Bafna Pharmaceuticals Ltd. compared to its sector?

    arrow

    PE ratio of Bafna Pharmaceuticals Ltd. is 50.71 whereas the sector PE ratio is 45.61.

    What is the market cap of Bafna Pharmaceuticals Ltd.?

    arrow

    Bafna Pharmaceuticals Ltd.’s market cap is 211.

    What are today’s High and Low prices of Bafna Pharmaceuticals Ltd. ?

    arrow

    Today’s High of Bafna Pharmaceuticals Ltd. is 91.89.
    Today’s Low of Bafna Pharmaceuticals Ltd. is 88.71.

    icon

    100% Safe & Secure Platform.

    Univest encrypts all data and transactions to ensure a completely secure experience for our members.

    Copyright

    2025 Univest. All rights reserved. | Designed with ❤️ in India
    About Univest
    About: Univest is a cutting-edge stock market platform designed to help traders and investors maximize their returns with expert-driven advisory services and seamless trading execution. Whether you're a seasoned trader or just starting, Univest simplifies your investment journey with actionable trade recommendations, AI-powered portfolio insights, and a fully integrated brokerage experience. With Univest, you gain access to proven stock market advisory, offering expert trade ideas for stocks, futures, options, and commodities. Our one-click trade execution feature eliminates slippage, ensuring instant execution through our advisory-first brokerage. Smart portfolio management allows you to identify underperforming stocks, optimize your investments, and receive real-time alerts. Additionally, Univest provides seamless investment opportunities beyond stocks, including mutual funds, bonds, fixed deposits, and insurance (coming soon). Join over 40 lakh active investors who trust Univest to make informed and profitable trading decisions. Start investing smarter today! 🚀  
    Attention Investors : To ensure a smooth trading experience and prevent unauthorized transactions, investors must update their mobile number and email ID with their stockbroker or depository participant. As per regulatory requirements, investors are required to pay a stipulated amount as an upfront margin for trading in the Cash/FO segment. We encourage all investors to regularly check their securities in the Consolidated Account Statement (CAS) issued by depository to verify their holdings.Always verify alerts and transaction details received directly from the exchange or NSDL before proceeding with any trades. Please do not make payments through unverified email links, WhatsApp, or SMS. Always trade through a registered stockbroker and verify all details before making financial decisions.
     
    Disclaimer: Investments in the securities market are subject to market risks. Please read all related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit. For more disclaimer /disclosure, visit https://univest.in/stock-broker or Univest App.We collect and use your contact information for legitimate business purposes, including providing updates on our products and services. We do not sell or rent your contact information to third parties. By submitting your details, you authorize us to contact you via Call/SMS, even if you are registered under DND. This authorization remains valid for 12 months.For grievances, please contact us at hello@unibrokers.in .
     
    Univest Stock Broking Disclosures
    Univest Stock Broking Private Limited - SEBI Reg. No. INZ000317437 (Stock Broker), NSE TM Code: 90392, BSE TM Code: 6866, MCX TM Code: 57290 and ICCL- Self Clearing Member Code: 6866, SEBI Reg. No. IN-DP-779-2024 (Participant), NSDL DP ID: IN304748.
     Risk Disclosures on Derivatives
    1. 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
    2. On an average, loss makers registered net trading loss close to ₹ 50,000
    3. Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
    4. Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
    Attention Investors: As per NSE circular dated July 6, 2022: https://nsearchives.nseindia.com/content/circulars/INSP52900.pdf, BSE circular dated July 6, 2022: https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20220706-55, MCX circular dated July 11, 2022: https://www.mcxindia.com/docs/default-source/circulars/english/2022/july/circular-418-2022.pdf?sfvrsn=9401991_0, investors are cautioned to abstain them from dealing in any schemes of unauthorised collective investments/portfolio management, indicative/ guaranteed/fixed returns / payments etc. 
    Investors are further cautioned to avoid practices like:
    a. Sharing 
    i) trading credentials – login id and passwords including OTPs.
    ii) trading strategies,
    iii) position details.
    b. Trading in leveraged products /derivatives like Options without proper understanding, which could lead to losses.
    c. Writing/ selling options or trading in option strategies based on tips, without basic knowledge and understanding of the product and its risks.
    d. Dealing in unsolicited tips through platforms like Whatsapp, Telegram, Instagram, YouTube, Facebook, SMS, calls, etc.
    e. Trading / Trading in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers.
     Kindly read the Advisory Guidelines For Investors as prescribed by the Exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client’s assets: https://nsearchives.nseindia.com/content/circulars/INSP49434.pdf
    Kindly, read the advisory as prescribed by the Exchange with reference to their circular: NSE/ISC/51035 dated January 14, 2022 regarding Updation of mandatory KYC fields by March 31, 2022: https://www.nseindia.com/resources/exchange-communication-circulars# 
    Attention Investors: Prevent unauthorised transactions in your Demat account by updating your mobile number with your depository participant. Receive alerts on your registered mobile number for debit and other important transactions in your Demat account directly from NSDL on the same day. Prevent unauthorised transactions in your Trading account by updating your mobile numbers/email addresses with your stock brokers. Receive information on your transactions directly from the Exchange on your mobile/email at the end of the day. Issued in the interest of investors. KYC is a one-time exercise while dealing in securities markets - once KYC is done through a SEBI-registered intermediary (Broker, DP), you need not undergo the same process again when you approach another intermediary. As a business, we don’t give stock tips and have not authorised anyone to trade on behalf of others. If you find anyone claiming to be part of Univest Stock Broking Private Limited and offering such services, please send us an email at hello@unibrokers.in
    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.
    Update your email ID and mobile number with your stockbroker/depository participant and receive an OTP directly from the depository on your registered email ID and/or mobile number. Check your securities/mutual funds/bonds in the Consolidated Account Statement (CAS) issued by NSDL every month.
    Attention Investors: SEBI has established an Online Dispute Resolution Portal (ODR Portal) for resolving disputes in the Indian Securities Market. This circular streamlines the existing dispute resolution mechanism, offering online conciliation and arbitration, benefiting investors and listed companies https://www.sebi.gov.in/legal/circulars/jul-2023/online-resolution-of-disputes-in-the- indian-securities-market_74794.html. ODR portal for Investors - https://smartodr.in/login.
    Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.
    General
    arrow down